炎症诱导慢性肾脏病患者外周单核细胞向破骨细胞分化:免疫与骨骼系统的交互作用
该研究通过体外培养实验,发现晚期CKD和HD患者外周血单核细胞自发形成破骨细胞增多且骨吸收活性增强,与RANKL和LIGHT表达升高相关;抑制这些细胞因子可减少破骨细胞形成,提示炎症单核细胞在矿物质骨病中起重要作用。
要点
- 晚期CKD和HD患者PBMCs自发破骨细胞生成及骨吸收活性显著增加。
- RANKL和LIGHT在PBMCs中表达升高,抑制两者可减少破骨细胞形成。
- OC前体(CD14+CD11b+CD51/61+)及CD14+CD16+单核细胞在晚期CKD和HD患者中增多。
核心结论
- 晚期CKD或HD患者的循环炎症单核细胞在体外可转分化为破骨细胞,参与矿物质骨病。
- LIGHT和RANKL是潜在治疗靶点。
研究设计与样本
- 体外培养实验,比较CKD和HD患者外周血单核细胞的破骨细胞生成潜力。
主要发现
- 晚期CKD和HD患者较早期CKD及健康供者破骨细胞形成和骨吸收活性显著增加。
- PBMCs中RANKL和LIGHT表达升高,特异性抑制后体外破骨细胞形成减少。
- 晚期CKD和HD患者OC前体(CD14+CD11b+CD51/61+)和CD14+CD16+单核细胞显著增加。
临床怎么用
- 提示监测炎症状态可能有助于评估CKD相关骨病。
- LIGHT和RANKL可能成为未来干预靶点。
局限性
- 原文未明确报告样本量、具体数值及P值。
- 为体外实验,结论需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammation and immune system alterations contribute to bone damage in many pathologies by inducing the differentiation of osteoclasts (OCs), the bone resorbing cells. This link is largely unexplored in chronic kidney disease (CKD) and haemodialysis (HD) patients, in which reduced renal function is accompanied by an increased inflammatory state and skeletal abnormality. METHODS: We used ex vivo culture experiments to investigate the osteoclastogenic potential of peripheral blood mononuclear cells (PBMCs) of CKD and HD patients, focusing on immune cell subsets and inflammatory cytokines such as LIGHT and receptor activator of nuclear factor κB ligand (RANKL). RESULTS: We observed spontaneous osteoclastogenesis with a significant increase in OC formation and bone resorbing activity in late-stage CKD and HD patients when compared with early-stage CKD patients and healthy donors, likely due to an increased expression of RANKL and LIGHT (homologous to Lymphotoxins exhibiting Inducible expression and competing with herpes simplex virus Glycoprotein D for herpes virus entry mediator [HVEM], a receptor expressed by T lymphocytes) in PBMCs. Specific inhibition of these cytokines in PBMCs isolated from CKD stages 3b-5 and HD patients induced the reduction of OC formation in vitro. The phenotypic characterization of peripheral blood cells revealed a significant increase of OC precursors (CD14+CD11b+CD51/61+) and CD14+CD16+ monocytes in advanced CKD and HD patients compared with the control group. CONCLUSIONS: Our results suggest that circulating inflammatory monocytes from advanced CKD or HD patients trans differentiate into OCs in vitro and play a relevant role in mineral bone disorders and that LIGHT and RANKL represent new potential therapeutic targets in these settings.
引用
- Cafiero C, Gigante M, Brunetti G, et al. Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems. Nephrol Dial Transplant. 2018. PMID: 28992140. doi:10.1093/ndt/gfx222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。